ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,118Medicare Part D Prescriptions Filled, Including Refills
$969K Total Retail Price of All Prescriptions
324 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
ATORVASTATIN CALCIUM 547 527
CRESTOR 491 467
ATELVIA 331 325
CELEBREX 267 263
DIOVAN 217 214
AMLODIPINE BESYLATE 203 193
METFORMIN HCL 166 166
EVISTA 163 137
LIDODERM 155 143
DIOVAN HCT 154 144
AMLODIPINE BESYLATE-BENAZEPRIL 150 150
ZETIA 146 146
OMEPRAZOLE 141 128
SIMVASTATIN 139 133
PATADAY 133 121
JANUVIA 132 132
GLIMEPIRIDE 127 118
TAMSULOSIN HCL 123 117
EXFORGE 117 114
ALLOPURINOL 115 112
ATENOLOL 113 110
LEVOTHYROXINE SODIUM 111 101
NEXIUM 109 109
CLOPIDOGREL 93 85
PRAVASTATIN SODIUM 84 76
VYTORIN 80 80
HYDROXYZINE HCL 79 74 R
PLAVIX 79 77
PANTOPRAZOLE SODIUM 78 78
CARVEDILOL 76 57
FUROSEMIDE 76 72
MECLIZINE HCL 75 71
NASONEX 73 71
GLYBURIDE-METFORMIN HCL 72 72 R
FINASTERIDE 70 70
METOPROLOL SUCCINATE 68 68
VOLTAREN 64 64
NAMENDA 61 61
TRIAMCINOLONE ACETONIDE 57 54
METOPROLOL TARTRATE 57 57
EXELON 56 56
DEXILANT 56 50
HYDROCHLOROTHIAZIDE 54 42
SPIRIVA 53 53
WELCHOL 53 52
BENICAR 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.